Study on Thrombosis Therapy in German Cancer Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01559883

Enrollment

Registered

2012-03-21

Start date

2012-02-29

Completion date

2013-12-31

Last updated

2014-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Deep Vein Thrombosis, Pulmonary Embolism

Keywords

cancer, thrombosis, pulmonary embolism, anticoagulation, low molecular weight heparin

Brief summary

The study aims to document the flow of German patients with cancer and acute deep vein thrombosis from first visit to diagnosis and treatment, the applied diagnostic procedures, and therapy modalities.

Interventions

OTHERno intervention is being made

This is a Non-Interventional Study (NIS)

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patient with cancer and acute deep vein thrombosis and/or pulmonary embolism

Exclusion criteria

* life expectancy less that 6 months * age less that 18 years

Design outcomes

Primary

Measure	Time frame
treatment time on low molecular weight heparin	1 year

Secondary

Measure	Time frame	Description
patient pathways	1 year	data collection on patient pathway: who is the referring physician, physician who diagnoses deep vein thrombosis (DVT)
risk factors for DVT	1 year	—

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026